Etk/Bmx transactivates vascular endothelial growth factor 2 and recruits phosphatidylinositol 3-kinase to mediate the tumor necrosis factor-induced angiogenic pathway
about
sameAs
AIP1 functions as an endogenous inhibitor of VEGFR2-mediated signaling and inflammatory angiogenesis in miceX-ray crystal structure of bone marrow kinase in the x chromosome: a Tec family kinaseTNF-alpha drives remodeling of blood vessels and lymphatics in sustained airway inflammation in mice.TNF primes endothelial cells for angiogenic sprouting by inducing a tip cell phenotypeEndothelial-specific transgenesis of TNFR2 promotes adaptive arteriogenesis and angiogenesis.Tumor necrosis factor receptor expression and signaling in renal cell carcinomaStabilization of VEGFR2 signaling by cerebral cavernous malformation 3 is critical for vascular developmentTNF-α signals through PKCζ/NF-κB to alter the tight junction complex and increase retinal endothelial cell permeabilityAdeno-associated virus-delivered polycistronic microRNA-clusters for knockdown of vascular endothelial growth factor in vivo.Human tumour necrosis factor: physiological and pathological roles in placenta and endometrium.Remodeling of cortical bone allografts mediated by adherent rAAV-RANKL and VEGF gene therapy.Tyrosine kinase BMX phosphorylates phosphotyrosine-primed motif mediating the activation of multiple receptor tyrosine kinasesCritical function of Bmx/Etk in ischemia-mediated arteriogenesis and angiogenesisFunctional analyses of the bone marrow kinase in the X chromosome in vascular endothelial growth factor-induced lymphangiogenesis.Caveolae participate in tumor necrosis factor receptor 1 signaling and internalization in a human endothelial cell line.Pathophysiology of lung injury induced by common bile duct ligation in mice.Differential functions of tumor necrosis factor receptor 1 and 2 signaling in ischemia-mediated arteriogenesis and angiogenesis.Stat3 orchestrates interaction between endothelial and tumor cells and inhibition of Stat3 suppresses brain metastasis of breast cancer cells.AIP1 Expression in Tumor Niche Suppresses Tumor Progression and Metastasis.Functional analyses of TNFR2 in physiological and pathological retina angiogenesis.Pathogenic angiogenesis in IBD and experimental colitis: new ideas and therapeutic avenues.Tumor necrosis factor-α: regulation of renal function and blood pressure.Gambogic acid inhibits angiogenesis and prostate tumor growth by suppressing vascular endothelial growth factor receptor 2 signaling.Release of nonmuscle myosin II from the cytosolic domain of tumor necrosis factor receptor 2 is required for target gene expression.Bmx tyrosine kinase transgene induces skin hyperplasia, inflammatory angiogenesis, and accelerated wound healing.BAFF and APRIL as TNF superfamily molecules and angiogenesis parallel progression of human multiple myeloma.BMX and its role in inflammation, cardiovascular disease, and cancer.Tumour necrosis factor in infectious disease.Regulation of TNF-α with a focus on rheumatoid arthritis.TNF-α signalling and inflammation: interactions between old acquaintances.Regulation of PI-3-Kinase and Akt Signaling in T Lymphocytes and Other Cells by TNFR Family MoleculesBreaking the 'harmony' of TNF-α signaling for cancer treatmentPotential role of O-GlcNAcylation and involvement of PI3K/Akt1 pathway in the expression of oncogenic phenotypes of gastric cancer cells in vitro.Anti-angiogenic activity of macrolactin A and its succinyl derivative is mediated through inhibition of class I PI3K activity and its signaling.Tumor necrosis factor-α: a key contributor to intervertebral disc degeneration.Discovery of novel vascular endothelial growth factor receptor 2 inhibitors: a virtual screening approach.Membrane tumor necrosis factor (TNF) induces p100 processing via TNF receptor-2 (TNFR2).Direct contact with perivascular tumor cells enhances integrin αvβ3 signaling and migration of endothelial cells.Activation of nonreceptor tyrosine kinase Bmx/Etk mediated by phosphoinositide 3-kinase, epidermal growth factor receptor, and ErbB3 in prostate cancer cells.Etk/Bmx mediates expression of stress-induced adaptive genes VEGF, PAI-1, and iNOS via multiple signaling cascades in different cell systems.
P2860
Q24318212-87E069EC-3758-4F1A-8E93-9CD7D5E9916FQ27672770-C0A1AB01-0D6B-4695-B2A5-C5597C7D33F5Q30490532-C6B59E0C-09FB-4B38-8FEB-6CFDDBB46A3EQ33323527-B2352F9F-26E6-46E4-A436-1E665D22B45EQ33927583-AF8F6F1D-80C7-4D7D-8067-1BE4E6558AB9Q34033309-B72E1FB1-6336-47F7-A545-95718045B19AQ34108757-F42681CE-2063-4E60-A56D-C85C8C8DCEFFQ34237700-F4AB0238-7D0C-425B-A60B-67F19E007184Q34262832-1A924A16-5E51-441B-BAFD-F62D51695FA7Q34280666-8B7AC057-2897-43CF-A2AD-6FB1294A4F43Q34345061-18EC07CE-A74C-4E45-A627-80F36DFC076EQ34743655-CDC152C1-216B-43C8-8E87-A889AB74A80CQ35001515-AC9B08DC-404B-48B7-9BC0-3042DCF4FAF8Q35019991-BE1E9074-37CB-484A-A138-4E8522ED2E35Q35083839-93BE54E1-B066-410F-B7F9-9B7B6E2A2040Q35147819-0E4DBE4E-89F8-4B38-AD84-0437BBAB314FQ35607323-BBD7587C-101F-4BF6-8302-05733B05D338Q35832897-63E626B4-EDD2-4AF2-9AA7-4D952922D893Q36021172-14BD86FE-80FA-4D23-A5C7-53FD113218CCQ36531084-4234D40E-8CE6-4D9F-8708-948A3B7462BCQ36803301-4C81AF88-9FB5-43A6-9AAE-04CA073ED0F1Q36836229-0275EB2E-537C-4771-9C8B-4CAD5942DD38Q36984546-D3704AA3-BA48-4571-8C2B-A23BE1903443Q37334658-FADF0A2B-AE89-4E2B-BBCA-8D8C7F0299C0Q37497256-294AAF48-B85D-4147-B317-AEFD1ABFC091Q37622417-7D3D4314-F0C8-4B9C-9959-4C69C9920BE8Q37997079-9EAE4CE5-2A9E-4FFF-8DDD-DABC9150A723Q38086506-4AC10934-D7CD-4F87-B02C-2271E76E7331Q38102876-97A73790-2A57-426B-9DB1-3B8BC77723E3Q38107792-2E307BE2-846B-4649-BA92-682B16815E49Q38113962-F3770279-4C91-4968-B51F-5B929E366AB2Q38410101-ED48B0E4-60DB-4D67-861C-03BBCC98901DQ38838503-7656ED42-E585-48F5-BB9C-97CB8CC02F77Q38924590-D1F76D48-1173-4452-AF97-41CF99211742Q39013640-CF1E799C-10AF-4722-942E-2910593B235DQ39292974-D7EDC59E-AC2E-4A0B-A17B-1F43A0760E91Q39758262-EC4A8EC1-32D3-4AE5-9CF8-BA48E744DCD6Q39986415-C4C52B4B-84E8-4080-862D-B30B7772099CQ40083890-65FCED6F-B1E4-4B19-BFD5-2B91C4DDDABFQ40443087-ADA26717-55E8-435F-BF4B-C53281697DC9
P2860
Etk/Bmx transactivates vascular endothelial growth factor 2 and recruits phosphatidylinositol 3-kinase to mediate the tumor necrosis factor-induced angiogenic pathway
description
2003 nî lūn-bûn
@nan
2003 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Etk/Bmx transactivates vascula ...... tor-induced angiogenic pathway
@ast
Etk/Bmx transactivates vascula ...... tor-induced angiogenic pathway
@en
Etk/Bmx transactivates vascula ...... tor-induced angiogenic pathway
@nl
type
label
Etk/Bmx transactivates vascula ...... tor-induced angiogenic pathway
@ast
Etk/Bmx transactivates vascula ...... tor-induced angiogenic pathway
@en
Etk/Bmx transactivates vascula ...... tor-induced angiogenic pathway
@nl
prefLabel
Etk/Bmx transactivates vascula ...... tor-induced angiogenic pathway
@ast
Etk/Bmx transactivates vascula ...... tor-induced angiogenic pathway
@en
Etk/Bmx transactivates vascula ...... tor-induced angiogenic pathway
@nl
P2093
P2860
P3181
P356
P1476
Etk/Bmx transactivates vascula ...... tor-induced angiogenic pathway
@en
P2093
Niklas Ekman
Rong Zhang
Yingqian Xu
Zhenhua Wu
P2860
P304
P3181
P356
10.1074/JBC.M310678200
P407
P50
P577
2003-12-19T00:00:00Z